Abbott Laboratories Income from Continuous Operations 2010-2024 | ABT

Abbott Laboratories annual/quarterly income from continuous operations history and growth rate from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
  • Abbott Laboratories income from continuous operations for the quarter ending September 30, 2024 was $1.646B, a 14.62% increase year-over-year.
  • Abbott Laboratories income from continuous operations for the twelve months ending September 30, 2024 was $5.767B, a 11.72% increase year-over-year.
  • Abbott Laboratories annual income from continuous operations for 2023 was $5.723B, a 17.45% decline from 2022.
  • Abbott Laboratories annual income from continuous operations for 2022 was $6.933B, a 1.95% decline from 2021.
  • Abbott Laboratories annual income from continuous operations for 2021 was $7.071B, a 58.15% increase from 2020.
Abbott Laboratories Annual Income from Continuous Operations
(Millions of US $)
2023 $5,723
2022 $6,933
2021 $7,071
2020 $4,471
2019 $3,687
2018 $2,334
2017 $353
2016 $1,063
2015 $2,606
2014 $1,721
2013 $1,988
2012 $237
2011 $1,126
2010 $4,626
2009 $5,746
Abbott Laboratories Quarterly Income from Continuous Operations
(Millions of US $)
2024-09-30 $1,646
2024-06-30 $1,302
2024-03-31 $1,225
2023-12-31 $1,594
2023-09-30 $1,436
2023-06-30 $1,375
2023-03-31 $1,318
2022-12-31 $1,033
2022-09-30 $1,435
2022-06-30 $2,018
2022-03-31 $2,447
2021-12-31 $1,989
2021-09-30 $2,100
2021-06-30 $1,189
2021-03-31 $1,793
2020-12-31 $2,158
2020-09-30 $1,232
2020-06-30 $537
2020-03-31 $544
2019-12-31 $1,049
2019-09-30 $960
2019-06-30 $1,006
2019-03-31 $672
2018-12-31 $655
2018-09-30 $552
2018-06-30 $718
2018-03-31 $409
2017-12-31 $-864
2017-09-30 $561
2017-06-30 $270
2017-03-31 $386
2016-12-31 $765
2016-09-30 $-357
2016-06-30 $599
2016-03-31 $56
2015-12-31 $695
2015-09-30 $596
2015-06-30 $786
2015-03-31 $529
2014-12-31 $634
2014-09-30 $438
2014-06-30 $425
2014-03-31 $224
2013-12-31 $324
2013-09-30 $644
2013-06-30 $476
2013-03-31 $544
2012-12-31 $-864
2012-09-30 $339
2012-06-30 $411
2012-03-31 $351
2011-12-31 $1,619
2011-09-30 $303
2011-06-30 $1,943
2011-03-31 $864
2010-12-31 $1,441
2010-09-30 $891
2010-06-30 $1,292
2010-03-31 $1,003
2009-12-31 $1,539
2009-09-30 $1,480
2009-06-30 $1,288
2009-03-31 $1,439
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $196.757B $40.109B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Stryker (SYK) United States $136.750B 30.82
Boston Scientific (BSX) United States $131.731B 37.87
EssilorLuxottica (ESLOY) France $109.710B 0.00
Medtronic (MDT) Ireland $102.865B 15.28
Haleon (HLN) United Kingdom $42.732B 27.76
Lonza Group Ag (LZAGY) Switzerland $42.382B 0.00
GE HealthCare Technologies (GEHC) United States $35.810B 18.57
ResMed (RMD) United States $33.540B 27.56
Terumo (TRUMY) Japan $28.681B 40.51
Koninklijke Philips (PHG) Netherlands $23.480B 17.97
Zimmer Biomet Holdings (ZBH) United States $20.795B 13.24
Insulet (PODD) United States $18.017B 71.75
Baxter (BAX) United States $14.940B 9.72
Smith & Nephew SNATS (SNN) United Kingdom $10.667B 0.00
BellRing Brands (BRBR) United States $9.606B 38.65
Bio-Rad Laboratories (BIO) United States $9.131B 31.03
Demant (WILYY) Denmark $8.251B 0.00
Lantheus Holdings (LNTH) United States $6.174B 14.35
Haemonetics (HAE) United States $3.938B 19.22
ICU Medical (ICUI) United States $3.868B 36.83
Prestige Consumer Healthcare (PBH) United States $3.840B 19.10
Perrigo (PRGO) Ireland $3.547B 10.44
Envista Holdings (NVST) United States $3.289B 24.50
QuidelOrtho (QDEL) United States $3.029B 19.50
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
GN Store Nord (GNNDY) Denmark $2.863B 18.36
Neogen (NEOG) United States $2.587B 29.85
LeMaitre Vascular (LMAT) United States $2.057B 49.98
Green Thumb Industries (GTBIF) United States $1.724B 30.17
AtriCure (ATRC) United States $1.482B 0.00
InMode (INMD) Israel $1.424B 8.57
Maravai LifeSciences Holdings (MRVI) United States $1.386B 0.00
AdaptHealth (AHCO) United States $1.305B 9.33
BioLife Solutions (BLFS) United States $1.214B 0.00
Curaleaf Holdings (CURLF) Canada $1.066B 0.00
Owens & Minor (OMI) United States $0.991B 7.74
CeriBell (CBLL) United States $0.926B 0.00
Phibro Animal Health (PAHC) United States $0.840B 14.81
Evolus (EOLS) United States $0.704B 0.00
Capricor Therapeutics (CAPR) United States $0.680B 0.00
VAREX IMAGING (VREX) United States $0.594B 26.20
Omeros (OMER) United States $0.570B 0.00
Surmodics (SRDX) United States $0.567B 0.00
Verano Holdings (VRNOF) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.463B 0.00
Quanterix (QTRX) United States $0.415B 0.00
Valneva SE (VALN) France $0.384B 0.00
ZimVie (ZIMV) United States $0.382B 32.16
Biote (BTMD) United States $0.328B 7.18
Viemed Healthcare (VMD) United States $0.317B 30.11
Canopy Growth (CGC) Canada $0.314B 0.00
Cerus (CERS) United States $0.292B 0.00
Sanara MedTech (SMTI) United States $0.289B 0.00
High Tide (HITI) Canada $0.269B 110.67
OraSure Technologies (OSUR) United States $0.264B 17.70
Zynex (ZYXI) United States $0.249B 52.07
Aurora Cannabis (ACB) Canada $0.247B 0.00
Organigram Holdings (OGI) Canada $0.209B 0.00
Utah Medical Products (UTMD) United States $0.208B 14.37
MacroGenics (MGNX) United States $0.207B 0.00
TerrAscend (TSNDF) Canada $0.205B 0.00
Sanuwave Health (SNWV) United States $0.188B 2.64
Brainsway (BWAY) Israel $0.180B 95.80
TriSalus Life Sciences (TLSI) United States $0.152B 0.00
Jin Medical (ZJYL) China $0.149B 0.00
FitLife Brands (FTLF) United States $0.148B 18.59
Quipt Home Medical (QIPT) United States $0.125B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.097B 0.00
Fonar (FONR) United States $0.096B 10.79
Veru (VERU) United States $0.095B 0.00
InterCure (INCR) Israel $0.072B 0.00
Rockwell Medical (RMTI) United States $0.072B 37.00
Jushi Holdings (JUSHF) United States $0.065B 0.00
Ayr Wellness (AYRWF) United States $0.060B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Exagen (XGN) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.050B 0.00
Modular Medical (MODD) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.047B 0.00
Safety Shot (SHOT) United States $0.045B 0.00
Allurion Technologies (ALUR) United States $0.027B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
Nephros (NEPH) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.007B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Agape ATP (ATPC) $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 12.84
SNDL (SNDL) Canada $0.000B 0.00